Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Robert Stein
Age : 69
Public asset : 1,101,138 USD
Country of residence : Unknown
Linked companies : Taro Pharmaceutical Industries Ltd. - MiMedx Group, Inc. - PolyPid Ltd. - Protagenic Therapeutics, Inc.

Biography of Robert Stein 
Dr. Robert B. Stein is an Executive Vice President-Research & Development at MiMedx Group, Inc., a Director & Chief Medical Officer at Protagenic Therapeutics, Inc., an Independent Director at PolyPid Ltd., a Member at American Association for Cancer Research, a Member at American Society of Clinical Oncology and a Member at New York Academy of Sciences. He is on the Board of Directors at Protagenic Therapeutics, Inc., Taro Pharmaceutical Industries Ltd. and PolyPid Ltd. Dr. Stein was previously employed as a President-Research & Development by Agenus, Inc., a Chief Executive Officer by KineMed, Inc., a President by Roche Palo Alto LLC, a Chief Scientific Officer by Incyte Pharmaceuticals, Inc., a President & Chief Scientific Officer by Incyte Genomics, Inc., an Executive VP-Research & Pre-Clinical Development by DuPont Merck Pharmaceutical Co., an Executive VP-Research & Pre-Clinical Development by DuPont Pharmaceuticals Co., a Head-Research & Development by Ligand Pharmaceuticals, Inc., a Head-Pharmacology by Merck, Sharpe & Dohme, a Founder by AgenTus Therapeutics, Inc., a Principal by Merck & Co., Inc., and a Chief Science Officer by Mirobio Ltd. He also served on the board at Atrinsic, Inc., Archemix Corp., diaDexus, Inc. /Old/ and Geron Corp. He received his undergraduate degree from Indiana University and a doctorate degree from Duke University.

Current positions of Robert Stein 
Holdings of Robert Stein 
Robert Stein : Personal Network 
Most Read News 
10/12CATHIE WOOD : ARK Invest's Wood warns upcoming economic downturn in China 'obvious'
10/15JACK DORSEY : Square CEO Dorsey says looking to build a bitcoin mining system - tweet
10/20JACK MA : Alibaba founder Ma spotted in Mallorca in rare trip abroad after China scrutiny
10/17ELON MUSK : Tesla's Musk dials into Volkswagen executive conference
10/22WARREN BUFFETT : Generali closer to controlling Cattolica after Buffett tenders shares - source
10/21ALEXANDRE RICARD : Pernod Ricard 1Q Sales Soar as Drinkers Head to the Bars
10/13WARREN BUFFETT : Buffett-backed Nubank turns a profit in Brazil
10/25ELON MUSK : WRAPUP 3-Tesla zooms past $1 trillion market cap on bet that the EV future is now
10/18BILL GATES : Electric vehicle battery startup ONE backed by BMW, Gates-led firm
10/20ELON MUSK : No Elon Musk Show during this Tesla quarterly call
More news

© 2021 People and Ownership :   
Robert Stein : Connections 

Latest news about Robert Stein 
08/17INSIDER TRENDS : MiMedx Group Insider Sale Interrupting 90-Day Buy Trend
2020INSIGHT-In Pennsylvania, signs that Trump's attacks on mail voting could backfire
2020Bastei Lübbe AG Announces Management Changes, with Effect from April 1, 2020 and August 1, 2020
2018Consultation prize - U.S.-China trade war fires bonanza for advisory firms
2017Robert Stein to Retire as President of R&D and to Join as Senior R&D Advisor of Agenus Inc., Effective April 1, 2017; Announces Reorganization of Business; to Phase Out Approximately 50 Positions
2016Bastei Lübbe AG Announces Board Changes; Approves Dividend
More news